Cargando…

Can we cure metastatic EGFR-mutated lung cancer today?

Detalles Bibliográficos
Autor principal:	Christopoulos, Petros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007876/ https://www.ncbi.nlm.nih.gov/pubmed/36915597 http://dx.doi.org/10.21037/tcr-22-2926

Ejemplares similares

Adoring ADAURA: can we cure lung cancer that harbors an EGFR mutation?
por: Melosky, Barbara
Publicado: (2023)

Liquid biopsies come of age in lung cancer
por: Christopoulos, Petros
Publicado: (2022)

De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer
por: Bozorgmehr, Farastuk, et al.
Publicado: (2021)

Tackling the challenge of brain involvement in driver-negative non-small cell lung cancer
por: Christopoulos, Petros
Publicado: (2023)

Refractive surgery: Where are we today?
por: Sachdev, Mahipal S
Publicado: (2020)

Precision diabetes: Where do we stand today?
por: Mohan, Viswanathan, et al.
Publicado: (2018)

Oesophageal Adenocarcinomas: Where Do We Stand Today?
por: Karstens, Karl-Frederick, et al.
Publicado: (2020)

Psychopharmacology Today: Where are We and Where Do We Go From Here?
por: Schwartz, Thomas L.
Publicado: (2010)

30 years of EFORT publications – where we stand today
por: Hoffmeyer, Pierre J.
Publicado: (2021)

Cataract surgery – Where are we today and what do we need?
por: Heda, Aarti, et al.
Publicado: (2022)

Tuberculosis in India - Can we ensure a test, treatment & cure for all?
por: Swaminathan, Soumya
Publicado: (2014)

Retrograde intra-renal surgery: Where are we today?
por: Chibber, Percy Jal
Publicado: (2008)

Multiple sclerosis: As we see it today and glimpses of tomorrow
por: Rammohan, Kottil W.
Publicado: (2009)

Treatment of Pancreatic Cancer: What Can We Really Predict Today?
por: Bachet, Jean-Baptiste, et al.
Publicado: (2011)

Double trouble: combined large-cell neuroendocrine and small-cell lung carcinoma
por: Fisch, David, et al.
Publicado: (2022)

The Journey for Lung Cancer Screening where we Stand Today
por: Wahla, Ali S., et al.
Publicado: (2022)

Simultaneous targeting of MET overexpression in EGFR mutation-positive non-small cell lung cancer can increase the benefit of EGFR-TKI therapy?
por: Kanemura, Hiroaki, et al.
Publicado: (2020)

Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

Cancer—Yesterday, Today, Tomorrow
por: Grigorean, Valentin Titus, et al.
Publicado: (2022)

Tumor Models and Drug Targeting In Vitro—Where Are We Today? Where Do We Go from Here?
por: Krüger, Marcus, et al.
Publicado: (2023)

Treatment strategy of EGFR-mutated non-small cell lung cancer
por: Tanaka, Fumihiro, et al.
Publicado: (2022)

Multiple mutations in the EGFR gene in lung cancer is rare but should not be forgettable
por: Miyata, Ryo, et al.
Publicado: (2022)

Can we cure relapsed/refractory Hodgkin lymphoma without a stem cell transplant?
por: Mei, Matthew G., et al.
Publicado: (2023)

Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
por: Guerrero, Rodrigo Motta, et al.
Publicado: (2022)

Professionalism today
por: Al-Rubaish, Abdullah M.
Publicado: (2010)

CUREs in biochemistry—where we are and where we should go
por: Bell, Jessica K., et al.
Publicado: (2016)

Critical points in the management of EGFR-mutated non-small cell lung cancer
por: Casaluce, Francesca, et al.
Publicado: (2022)

Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer
por: Magios, Nikolaus, et al.
Publicado: (2021)

The Challenge Arising from New Knowledge about Immune and Inflammatory Skin Diseases: Where We Are Today and Where We Are Going
por: Campanati, Anna, et al.
Publicado: (2022)

Which is better, EGFR-TKI mono or combination for non-small cell lung cancer with mutated EGFR?
por: Tanzawa, Shigeru, et al.
Publicado: (2019)

Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer
por: Kian, Waleed, et al.
Publicado: (2022)

Hemodynamic Monitoring Today
por: Cecconi, Maurizio, et al.
Publicado: (2011)

The challenges of today and tomorrow
por: Jankharia, Bhavin
Publicado: (2008)

The sway of interventions today…
por: Jain, Sanjay N
Publicado: (2013)

TP53 co-mutations as an independent prognostic factor in 2nd and further line therapy—EGFR mutated non-small cell lung cancer IV patients treated with osimertinib
por: Roeper, Julia, et al.
Publicado: (2022)

Complex EGFR mutations in non-small cell lung cancer: a distinct entity?
por: Bieńkowski, Michał, et al.
Publicado: (2022)

Cancer drug development yesterday, today and tomorrow
por: Izbicka, Elzbieta, et al.
Publicado: (2023)

Chemotherapy for ovarian cancer: yesterday, today and tomorrow
por: Kaye, S B
Publicado: (2003)

Robots Used Today that we Did Not Expect 20 Years Ago (from the Editorial Board Members)
por: Gulrez, Tauseef
Publicado: (2021)

Can Proteins Cure Dental Cavities?
por: Damle, S. G.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9vbfjdmkp2ehrkai4bvu9pedb9